Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Cost of Goods Sold

Acadia Pharmaceutica Cost of Goods Sold Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Cost of Goods Sold from 2010 to 2020.
  • Acadia Pharmaceutica Cost of Goods Sold for the quarter ending June 06, 2020 was $70m a 3.52% increase of 2m year over year
  • Acadia Pharmaceutica Cost of Goods Sold for the last 12 months ending June 06, 2020 was $278m a 10.03% increase of 28m year over year
  • Acadia Pharmaceutica Annual Cost of Goods Sold for 2019 was $260m a 20.96% increase of 54m from 2018
  • Acadia Pharmaceutica Annual Cost of Goods Sold for 2018 was $205m a 21.04% increase of 43m from 2017
  • Acadia Pharmaceutica Annual Cost of Goods Sold for 2017 was $162m a 36.09% increase of 59m from 2016
Other Income Statement Metrics:
  • Acadia Pharmaceutica EBITDA for the quarter ending December 12, 2018 was $-67m a 18.74% decrease of -12m year over year
  • Acadia Pharmaceutica Net Income for the quarter ending December 12, 2018 was $-65m a 17.10% decrease of -11m year over year
  • Acadia Pharmaceutica Total Revenue for the quarter ending September 09, 2018 was $58m a 25.29% increase of 15m year over year
View Chart On Koyfin

Quarterly ACAD Cost of Goods Sold Data

06/2020$70m
03/2020$78m
12/2019$63m
09/2019$67m
06/2019$72m
03/2019$58m
12/2018$53m
09/2018$58m
06/2018$52m
03/2018$43m

Annual ACAD Cost of Goods Sold Data

2019$260m
2018$205m
2017$162m
2016$104m
2015$76m
2014$61m
2013$27m
2012$19m
2011$17m
2010$21m